Incorporated in 1994, Claris Lifesciences Limited (CLL) is an Ahmedabad based pharmaceutical company. Claris is the largest Indian sterile injectables pharmaceutical companies with a presence in 76 countries worldwide. Claris offers 113 products across multiple markets and therapeutic areas. All of these products are off-patent products.
Claris's product range across various therapeutic segments, including anaesthesia, critical care, anti-infectives, renal care, infusion therapy, enteral nutrition, parenteral nutrition and oncology.
Companies more than half of the sales come from international markets and have a strong presence in regions of Latin America, the Middle East, Africa and Central, South East and Far East Asia.
Claris's manufacturing facilities are located in Ahmedabad, India and approved by foreign regulatory authorities. The manufacturing facilities are ISO 9001-2000 and WHO GMP certified.
Company Promoters:
The promoters of the company are:1. Mr. Arjun S. Handa
2. Sarjan Financial Private Limited
Company Financials:
| Particulars | For the year/period ended (in Rs. million) | |||||
| 31-Dec-09 | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | 31-Dec-05 | ||
| Total Income | 7,594.01 | 7,639.00 | 6,238.16 | 4,026.74 | 2,923.61 | |
| Profit After Tax (PAT) | 1,303.80 | 1,083.95 | 832.72 | 466.93 | 179.30 | |
Objects of the Issue:
The objects of the issue are:1. Setting up of a new plant comprising a small volume parenterals line, a PVC bag line, a non-PVC bag line and a fat emulsion line.
2. Setting up of a new manufacturing line for propofol and other fat emulsion products at our existing plant, Clarion IV.
3. Construction of a facility for research and development at our Clarion manufacturing facilities.
4. Prepayment of an identified term loan.
5. General corporate purposes.
Issue Detail:
»» Issue Open: Nov 24, 2010 - Nov 26, 2010
»» Issue Type: 100% Book Built Issue IPO
»» Issue Size: Equity Shares of Rs. 10
»» Issue Size: Rs. 300.00 Crore
»» Face Value: Rs. 10 Per Equity Share
»» Issue Price: Rs. 278 - Rs. 293 Per Equity Share
»» Market Lot: 22 Shares
»» Minimum Order Quantity: 22 Shares
»» Listing At: BSE
Maximum Subscription Amount for Retail Investor: Rs. 2,00,000
Claris Lifesciences Ltd IPO Grading / Rating
Fitch Ratings India Private Limited has assigned an IPO Grade 3 to Claris Lifesciences Ltd IPO. This means as per Fitch, company has 'Average Fundamentals'. Fitch assigns IPO grading on a scale of 5 to 1, with Grade 5 indicating strong fundamentals and Grade 1 indicating poor fundamentals.Click here to download the Fitch IPO Grading Document for Claris Lifesciences Ltd.
Check IPO Ratings from other stock analysts.
Claris Lifesciences Limited IPO Tags:
Claris Lifesciences IPO, Claris IPO, Claris Lifesciences Ltd IPO Bidding, Claris Life IPO Allotment Status, Claris IPO drhp and Claris IPO listing.